|
tranexamic acid Clinical Trials
8 actively recruiting trials across 2 locations
▼ -1 trial since June 2026
Also known as: Cyclokapron®, SteriMax Inc., TXA, Cyklokapron
Pipeline
Phase 2: 2Phase 3: 3Phase 4: 1Phase 1/2: 1
Top Sponsors
- University of Manitoba1
- University of Aarhus1
- Stanford University1
- Second Affiliated Hospital, School of Medicine, Zhejiang University1
- RenJi Hospital1
Indications
- Cancer6
- Lung Cancer2
- End-stage Liver Disease (ESLD)1
- Tranexamic Acid1
- Anterior Cruciate Ligament Reconstruction1
Other6 trials
Stanford, California1 trial
Houston, Texas1 trial
A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients
M D Anderson Cancer Center
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.